Information:
Fel:
ID
22075
Beskrivning
Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00415363
Länk
https://clinicaltrials.gov/show/NCT00415363
Nyckelord
Versioner (1)
- 2017-05-18 2017-05-18 -
Uppladdad den
18 maj 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non Small Cell Lung Cancer NCT00415363
Eligibility Non Small Cell Lung Cancer NCT00415363
- StudyEvent: Eligibility
Similar models
Eligibility Non Small Cell Lung Cancer NCT00415363
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Lung Carcinoma Metastatic in the Brain
Item
having radiologically proven brain metastases of lung cancer
boolean
C1334441 (UMLS CUI [1])
Whole brain radiotherapy | Gray unit of radiation dose Quantity Week Quantity | enzastaurin
Item
having received whole brain radiotherapy with either 30 grays in 2 weeks or 20 grays in one week. treatment with enzastaurin must start within 14 days after the last fraction of the whole brain radiotherapy
boolean
C1520143 (UMLS CUI [1])
C0556636 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0439230 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C1327830 (UMLS CUI [3])
C0556636 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0439230 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C1327830 (UMLS CUI [3])
Radiotherapy to brain | Radiosurgery Quantity
Item
no other previous radiotherapy to the brain except for radiosurgery at one occasion
boolean
C0948319 (UMLS CUI [1])
C0085203 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0085203 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Organ function Laboratory Procedures
Item
adequate organ function as measured by appropriate laboratory tests.
boolean
C0678852 (UMLS CUI [1,1])
C0022885 (UMLS CUI [1,2])
C0022885 (UMLS CUI [1,2])
Age
Item
age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
Able to swallow Tablets | Condition Interferes with Oral medication administration | Vomiting | Partial bowel obstruction
Item
inability to swallow tablets or show conditions which could interfere with oral medication intake (e.g. vomiting, partial bowel obstruction).
boolean
C2712086 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0001563 (UMLS CUI [2,3])
C0042963 (UMLS CUI [3])
C1328480 (UMLS CUI [4])
C0039225 (UMLS CUI [1,2])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0001563 (UMLS CUI [2,3])
C0042963 (UMLS CUI [3])
C1328480 (UMLS CUI [4])
Antiepileptic Agents Unable to discontinue | Carbamazepine | Phenobarbital | Phenytoin
Item
inability to discontinue use of certain anti-epileptic drugs such as, carbamazepine, phenobarbital or phenytoin.
boolean
C0003299 (UMLS CUI [1,1])
C1548265 (UMLS CUI [1,2])
C0006949 (UMLS CUI [2])
C0031412 (UMLS CUI [3])
C0031507 (UMLS CUI [4])
C1548265 (UMLS CUI [1,2])
C0006949 (UMLS CUI [2])
C0031412 (UMLS CUI [3])
C0031507 (UMLS CUI [4])
Warfarin
Item
concurrent administration of warfarin
boolean
C0043031 (UMLS CUI [1])
Hemophilia
Item
hemophilia
boolean
C0684275 (UMLS CUI [1])
Cancer treatment Systemic
Item
having had any systemic anti-cancer treatment within the last 2 weeks prior to enrolment.
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,2])